当前位置: X-MOL 学术ACS Med. Chem. Lett. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
2-Amino-N-heteroaryl-nicotimamides as Nav1.8 Inhibitors
ACS Medicinal Chemistry Letters ( IF 4.2 ) Pub Date : 2020-11-23 , DOI: 10.1021/acsmedchemlett.0c00568
Benjamin E Blass 1
Affiliation  

Hameed, S. Nav 1.7 and Nav 1.8: Role in the pathophysiology of pain. Mol. Pain 2019, 15, 10.1177/2F1744806919858801. Han, C.; Huang, J.; Waxman, S. G. Sodium channel Nav 1.8: Emerging links to human disease. Neurology 2016, 86 (5), 473–483. Gilchrist, J.; Bosmans, F. Using voltage-sensor toxins and their molecular targets to investigate Nav1.8 gating. J. Physiol. 2018, 596 (10), 1863–1872. The author declares no competing financial interest. The author declares no competing financial interest. This article has not yet been cited by other publications.

中文翻译:

2-氨基-N-杂芳基-烟酰胺作为 Nav1.8 抑制剂

哈米德,S.Na v 1.7 和 Na v 1.8:在疼痛病理生理学中的作用。摩尔。疼痛 201915,10.1177 / 2F1744806919858801。韩,C黄,J瓦克斯曼,SG钠通道 Na v 1.8:与人类疾病的新联系。神经病学 2016 年86(5),473-483。吉尔克里斯特,J博斯曼斯,F.使用电压传感器毒素及其分子靶标研究 Na v 1.8 门控。J.生理学。 2018 , 596 (10), 1863–1872。作者声明没有竞争性经济利益。作者声明没有竞争性经济利益。这篇文章还没有被其他出版物引用。
更新日期:2020-12-10
down
wechat
bug